Vanguard Group Inc. increased its stake in Pfizer Inc. by 0.2% in the third quarter, bringing its total holdings to 534,315,020 shares valued at approximately $13.61 billion, representing 9.40% of the company. Pfizer also reported better-than-expected Q4 earnings with $0.66 EPS and $17.56 billion in revenue, exceeding analyst estimates. The company declared a quarterly dividend of $0.43 per share, resulting in an annualized yield of 6.2%.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vanguard Group Inc. Has $13.61 Billion Stock Position in Pfizer Inc. $PFE
Vanguard Group Inc. increased its stake in Pfizer Inc. by 0.2% in the third quarter, bringing its total holdings to 534,315,020 shares valued at approximately $13.61 billion, representing 9.40% of the company. Pfizer also reported better-than-expected Q4 earnings with $0.66 EPS and $17.56 billion in revenue, exceeding analyst estimates. The company declared a quarterly dividend of $0.43 per share, resulting in an annualized yield of 6.2%.